Salem Radio Network News Friday, October 3, 2025

Health

J&J-backed HistoSonics explores sale at $2.5 billion valuation, FT reports

Carbonatix Pre-Player Loader

Audio By Carbonatix

(Reuters) -HistoSonics, a medical technology company backed by Johnson & Johnson, is exploring a potential sale at a valuation of more than $2.5 billion after receiving multiple takeover offers, the Financial Times reported on Friday.

Medtronic, GE HealthCare and J&J itself are evaluating the business, the FT reported, citing people familiar with the matter.

Final bids are expected in the coming weeks, though a deal is not guaranteed, the report said, adding that Citigroup is advising HistoSonics on the sale.

The company, which developed a sonic beam therapy to target liver tumors, had also explored a public listing but a sale was prioritized as market volatility has hampered IPO activity, the FT said.

J&J and HistoSonics did not immediately reply to Reuters requests for comment outside regular business hours.

(Reporting by Bipasha Dey in Bengaluru; Editing by Sonia Cheema and Savio D’Souza)

Previous
Next
The Media Line News
Salem Media, our partners, and affiliates use cookies and similar technologies to enhance your browsing experience, analyze site traffic, personalize site content, and deliver relevant video recommendations. By using this website and continuing to navigate, you consent to our use of such technologies and the sharing of video viewing activity with third-party partners in accordance with the Video Privacy Protection Act and other privacy laws. Privacy Policy
OK
X CLOSE